HOLDING MAESTRO
Holdings
own 2025 accountsThis companyHOLDING MAESTRO2 holdings, 2 countries
2025 accounts
Belgium 1 Year Equity Result
- BE BIO-X DIAGNOSTICS51.02% 2025€3.6m result €56,097 (2025)
Europe 1 Year Equity Result
- FR FINADIAG SAS12.57% 2024€2.8m result €702,573 (2024)
Source: list of holdings in its own 2025 accounts. Holdings that file themselves stand with their latest accounts, the others with the amounts of that list, in their own currency.
At the same address
Dieweg 44, 1180 Uccle · 1 other company| Todorova, Tatiana (sole trader)
establishment since 02-10-2017 |
founded in 2017 0681.785.284 |
Holdings and subsidiaries
2 holdings · 2 subsidiaries, including indirect onesHoldings 2
Share, source and own figures per holding (2)
Source for every holding own accounts 2025
- Bio -X DiagnosticssubsidiaryEquity €3.6m Profit of €56,097 in 2025 (profit of €174,667 in 2024) Checked score 8951.02%
- FINADIAG SASFREquity €2.8mResult €702,57312.57%
All subsidiaries, including indirect ones 2
HOLDING MAESTRO or one of its subsidiaries holds more than half of the shares of these companies. A company it consolidates per the LEI register is listed too.
Bio -X Diagnostics 51.02%1 subsidiary
- ADIAGENEFR 100%
Holdings through the years 2015 to 2025
| Name | 2015 | 2016 | 2017 | 2018 | 2019 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Bio -X Diagnostics | 28.7% | 17.86% | 51.02% | |||||
| FINADIAG SASFR | 12.57% | |||||||
Source: list of holdings in its own accounts
Board mandates elsewhere
1 board mandateBoard mandates of HOLDING MAESTROHOLDING MAESTRO sits on their board1
Connections & network
3 current directorsThe board mandates are listed under Board mandates elsewhere. The network lets you explore the same ties.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.